Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Addex Therapeutics ADR ADXN

Healthcare Biotechnology
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ADXN)

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

Accesswire July 8, 2021

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

Accesswire June 23, 2021

Enamine Extend Collaboration With Prominent Swiss Biotech

Business Wire February 24, 2021
View More News ››

Opinion & Analysis (NDAQ:ADXN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ADXN)

(ADXN) Pivots Trading Plans and Risk Controls

JUST IN: $ADXN (ADXN) Pivots Trading Plans and Risk Controls2024-09-14 13:58:00 ET Stock Traders Daily has produced this trading report...
whytestocks - September 14, 2024

(ADXN) Trading Report

JUST IN: $ADXN (ADXN) Trading Report2024-08-30 04:24:00 ET Stock Traders Daily has produced this trading report using a proprietary...
whytestocks - August 30, 2024

Addex and Indivior Select Clinical Candidates from GABAB Pos

JUST IN: $ADXN Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationAd Hoc...
whytestocks - August 27, 2024

Todays move will be record

This is what investors heres have been waiting for, I'll flip a few today
Tradinghands - August 27, 2024
View more Bullboard ››

Mirasol Resources Ltd.

Mirasol Resources Ltd.

Mirasol Resources Ltd. is a Canada-based mineral exploration company focused on quality copper, gold and silver discoveries ...
View More »